| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 9.36e-10 | 20 | 111 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 4.38e-08 | 36 | 111 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 RANBP2 RGPD8 ARHGAP23 RGPD1 ARHGAP11A ECT2 RGPD3 ACAP2 RGPD5 | 3.60e-06 | 279 | 111 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 8.42e-06 | 50 | 111 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.12e-05 | 53 | 111 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RANBP2 RGPD8 ARHGAP23 FRMD7 RGPD1 ARHGAP11A ECT2 RGPD3 AKAP13 ACAP2 RGPD5 | 2.55e-05 | 507 | 111 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RANBP2 RGPD8 ARHGAP23 FRMD7 RGPD1 ARHGAP11A ECT2 RGPD3 AKAP13 ACAP2 RGPD5 | 2.55e-05 | 507 | 111 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | tubulin binding | MAP4 KIF26A KIF26B PRC1 NEDD1 MAP10 CEP350 ALMS1 TTLL4 FGF13 KIF18B | 2.67e-05 | 428 | 111 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | microtubule binding | 5.61e-05 | 308 | 111 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 RANBP2 RGPD8 ARHGAP23 RGPD1 RICTOR ARHGAP11A ECT2 DCP1B RGPD3 FGF13 ACAP2 RGPD5 | 7.22e-05 | 656 | 111 | 13 | GO:0008047 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | PHACTR2 MAP4 VEZT KIF26A KIF26B PRC1 NEDD1 MAP10 CEP350 ABLIM1 ALMS1 TTLL4 FGF13 IQCJ-SCHIP1 PLEKHH2 KIF18B | 3.73e-04 | 1099 | 111 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | small GTPase binding | 4.30e-04 | 321 | 111 | 8 | GO:0031267 | |
| GeneOntologyMolecularFunction | isomerase activity | 7.17e-04 | 192 | 111 | 6 | GO:0016853 | |
| GeneOntologyMolecularFunction | GTPase binding | 9.10e-04 | 360 | 111 | 8 | GO:0051020 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.72e-03 | 398 | 111 | 8 | GO:0061659 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 4.65e-10 | 9 | 109 | 5 | GO:0033133 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 6.92e-10 | 20 | 109 | 6 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 9.27e-10 | 10 | 109 | 5 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 4.68e-09 | 13 | 109 | 5 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 7.24e-09 | 14 | 109 | 5 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.64e-06 | 38 | 109 | 5 | GO:0000413 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | RGPD4 RANBP2 RGPD8 WRN RGPD1 POM121L2 ECT2 DCP1B RGPD3 EIF2AK3 RGPD5 | 3.46e-06 | 362 | 109 | 11 | GO:0034504 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP4 SIK3 PRC1 NEDD1 MAP10 CDC14B MECP2 CEP350 ALMS1 ATXN7 TTLL4 CFAP74 FGF13 TACC1 KIF18B | 5.82e-06 | 720 | 109 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 9.29e-06 | 195 | 109 | 8 | GO:0006606 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 9.67e-06 | 54 | 109 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | microtubule-based process | MAP4 KIF26A KIF26B SIK3 PRC1 NEDD1 MAP10 CDC14B MECP2 CEP350 CFAP54 ALMS1 ATXN7 TTLL4 CFAP74 FGF13 TACC1 KIF18B | 1.04e-05 | 1058 | 109 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | import into nucleus | 1.16e-05 | 201 | 109 | 8 | GO:0051170 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 3.71e-05 | 71 | 109 | 5 | GO:0006111 | |
| GeneOntologyBiologicalProcess | nuclear export | 5.75e-05 | 185 | 109 | 7 | GO:0051168 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.56e-04 | 217 | 109 | 7 | GO:0006403 | |
| GeneOntologyBiologicalProcess | nuclear transport | 1.80e-04 | 378 | 109 | 9 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 1.80e-04 | 378 | 109 | 9 | GO:0006913 | |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 2.71e-04 | 168 | 109 | 6 | GO:0031109 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 3.09e-04 | 111 | 109 | 5 | GO:0006094 | |
| GeneOntologyBiologicalProcess | RNA transport | 3.37e-04 | 175 | 109 | 6 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 3.37e-04 | 175 | 109 | 6 | GO:0050657 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 3.64e-04 | 115 | 109 | 5 | GO:0019319 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 3.69e-04 | 178 | 109 | 6 | GO:0051236 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 4.13e-04 | 66 | 109 | 4 | GO:0007019 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 4.59e-04 | 121 | 109 | 5 | GO:0046364 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.13e-10 | 8 | 111 | 5 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 9.51e-10 | 10 | 111 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 7.43e-09 | 14 | 111 | 5 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 3.13e-08 | 18 | 111 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 5.61e-08 | 20 | 111 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 7.33e-08 | 21 | 111 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear pore | 1.12e-06 | 101 | 111 | 7 | GO:0005643 | |
| GeneOntologyCellularComponent | mitotic spindle midzone | 7.76e-05 | 16 | 111 | 3 | GO:1990023 | |
| GeneOntologyCellularComponent | inclusion body | 1.18e-04 | 90 | 111 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | spindle | MAP4 PRC1 NEDD1 MAP10 ECT2 CDC14B CEP350 CEP170 ALMS1 KIF18B | 2.07e-04 | 471 | 111 | 10 | GO:0005819 |
| GeneOntologyCellularComponent | mitotic spindle | 7.19e-04 | 201 | 111 | 6 | GO:0072686 | |
| GeneOntologyCellularComponent | nuclear body | TCF20 RAPH1 HIPK1 AFF3 WRN ZC3H18 ECT2 PIAS2 NOP58 RBM27 PLEKHH2 KIF18B COIL | 1.00e-03 | 903 | 111 | 13 | GO:0016604 |
| GeneOntologyCellularComponent | microtubule organizing center | MAP4 HIPK1 WRN NEDD1 MAP10 ECT2 CDC14B MECP2 CEP350 CEP170 ALMS1 TTLL4 TACC1 | 1.18e-03 | 919 | 111 | 13 | GO:0005815 |
| GeneOntologyCellularComponent | spindle midzone | 1.25e-03 | 40 | 111 | 3 | GO:0051233 | |
| GeneOntologyCellularComponent | fibrillar center | 1.47e-03 | 156 | 111 | 5 | GO:0001650 | |
| GeneOntologyCellularComponent | microtubule | 2.16e-03 | 533 | 111 | 9 | GO:0005874 | |
| GeneOntologyCellularComponent | nuclear membrane | 2.62e-03 | 349 | 111 | 7 | GO:0031965 | |
| GeneOntologyCellularComponent | centrosome | HIPK1 WRN NEDD1 MAP10 ECT2 CDC14B MECP2 CEP350 CEP170 ALMS1 TACC1 | 2.64e-03 | 770 | 111 | 11 | GO:0005813 |
| GeneOntologyCellularComponent | nuclear envelope | 3.00e-03 | 560 | 111 | 9 | GO:0005635 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 3.06e-08 | 16 | 85 | 5 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 4.39e-07 | 26 | 85 | 5 | MP:0012058 | |
| MousePheno | decreased tumor latency | 9.33e-07 | 30 | 85 | 5 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 1.11e-06 | 31 | 85 | 5 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 1.79e-06 | 34 | 85 | 5 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 3.61e-06 | 39 | 85 | 5 | MP:0012128 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 3.82e-06 | 107 | 85 | 7 | MP:0003694 | |
| MousePheno | abnormal blastocyst hatching | 5.49e-06 | 113 | 85 | 7 | MP:0003693 | |
| MousePheno | abnormal susceptibility to weight gain | 1.74e-05 | 309 | 85 | 10 | MP:0011117 | |
| MousePheno | increased incidence of tumors by chemical induction | 2.34e-05 | 141 | 85 | 7 | MP:0004499 | |
| MousePheno | enlarged epididymis | 3.02e-05 | 99 | 85 | 6 | MP:0004931 | |
| MousePheno | aneuploidy | 3.36e-05 | 61 | 85 | 5 | MP:0004024 | |
| MousePheno | increased sarcoma incidence | 3.57e-05 | 102 | 85 | 6 | MP:0002032 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 5.85e-05 | 286 | 85 | 9 | MP:0008873 | |
| MousePheno | increased hepatocellular carcinoma incidence | 6.55e-05 | 70 | 85 | 5 | MP:0003331 | |
| MousePheno | abnormal epididymis size | 6.65e-05 | 166 | 85 | 7 | MP:0004926 | |
| MousePheno | abnormal preimplantation embryo development | 8.02e-05 | 171 | 85 | 7 | MP:0009781 | |
| MousePheno | increased incidence of induced tumors | 8.63e-05 | 173 | 85 | 7 | MP:0002021 | |
| MousePheno | increased lung carcinoma incidence | 1.10e-04 | 78 | 85 | 5 | MP:0008714 | |
| MousePheno | abnormal cell nucleus morphology | 1.27e-04 | 184 | 85 | 7 | MP:0003111 | |
| MousePheno | abnormal physiological response to xenobiotic | RGPD4 RANBP2 RGPD8 KIF26A HIPK1 RGPD1 IRF1 GABBR2 USP38 RGPD3 RETNLB EIF2AK3 HRH3 | 1.70e-04 | 662 | 85 | 13 | MP:0008872 |
| MousePheno | abnormal chromosome number | 1.75e-04 | 86 | 85 | 5 | MP:0004023 | |
| MousePheno | increased circulating interleukin-13 level | 2.18e-04 | 4 | 85 | 2 | MP:0008608 | |
| MousePheno | abnormal incidence of induced tumors | 2.27e-04 | 269 | 85 | 8 | MP:0013151 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 4.25e-04 | 160 | 85 | 6 | MP:0005659 | |
| MousePheno | increased respiratory system tumor incidence | 4.83e-04 | 107 | 85 | 5 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 4.83e-04 | 107 | 85 | 5 | MP:0008014 | |
| MousePheno | increased hepatobiliary system tumor incidence | 5.71e-04 | 111 | 85 | 5 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 5.71e-04 | 111 | 85 | 5 | MP:0008019 | |
| MousePheno | increased malignant tumor incidence | 5.92e-04 | 237 | 85 | 7 | MP:0002018 | |
| MousePheno | abnormal temporal memory | 6.22e-04 | 239 | 85 | 7 | MP:0001468 | |
| MousePheno | abnormal rod electrophysiology | 7.83e-04 | 119 | 85 | 5 | MP:0004021 | |
| MousePheno | decreased susceptibility to weight gain | 9.37e-04 | 186 | 85 | 6 | MP:0010182 | |
| MousePheno | abnormal circulating interleukin-13 level | 9.99e-04 | 8 | 85 | 2 | MP:0008607 | |
| MousePheno | abnormal Bergmann glial cell morphology | 9.99e-04 | 8 | 85 | 2 | MP:0010387 | |
| MousePheno | abnormal chromosome morphology | 1.01e-03 | 126 | 85 | 5 | MP:0003702 | |
| Domain | Ran_BP1 | 2.32e-11 | 12 | 104 | 6 | PF00638 | |
| Domain | RANBD1 | 2.32e-11 | 12 | 104 | 6 | PS50196 | |
| Domain | RanBD | 4.28e-11 | 13 | 104 | 6 | SM00160 | |
| Domain | Ran_bind_dom | 4.28e-11 | 13 | 104 | 6 | IPR000156 | |
| Domain | Grip | 2.19e-09 | 11 | 104 | 5 | SM00755 | |
| Domain | GRIP | 2.19e-09 | 11 | 104 | 5 | PF01465 | |
| Domain | GRIP_dom | 3.73e-09 | 12 | 104 | 5 | IPR000237 | |
| Domain | GRIP | 3.73e-09 | 12 | 104 | 5 | PS50913 | |
| Domain | PH_dom-like | RGPD4 RANBP2 RGPD8 RAPH1 ARHGAP23 FRMD7 RGPD1 DGKD ECT2 DCP1B RGPD3 AKAP13 PLEKHH2 ACAP2 RGPD5 | 1.38e-08 | 426 | 104 | 15 | IPR011993 |
| Domain | GCC2_Rab_bind | 3.13e-08 | 7 | 104 | 4 | IPR032023 | |
| Domain | Rab_bind | 3.13e-08 | 7 | 104 | 4 | PF16704 | |
| Domain | - | RGPD4 RANBP2 RGPD8 RAPH1 ARHGAP23 FRMD7 RGPD1 DGKD ECT2 DCP1B RGPD3 AKAP13 PLEKHH2 ACAP2 | 3.55e-08 | 391 | 104 | 14 | 2.30.29.30 |
| Domain | - | 1.86e-07 | 10 | 104 | 4 | 1.10.220.60 | |
| Domain | TPR-contain_dom | 1.93e-04 | 150 | 104 | 6 | IPR013026 | |
| Domain | TPR_REGION | 3.22e-04 | 165 | 104 | 6 | PS50293 | |
| Domain | TPR | 3.22e-04 | 165 | 104 | 6 | PS50005 | |
| Domain | TPR-like_helical_dom | 3.27e-04 | 233 | 104 | 7 | IPR011990 | |
| Domain | TPR | 7.74e-04 | 129 | 104 | 5 | SM00028 | |
| Domain | TPR_repeat | 8.89e-04 | 133 | 104 | 5 | IPR019734 | |
| Domain | PH | 9.33e-04 | 278 | 104 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 9.53e-04 | 279 | 104 | 7 | PS50003 | |
| Domain | PH_domain | 9.73e-04 | 280 | 104 | 7 | IPR001849 | |
| Domain | - | 1.06e-03 | 207 | 104 | 6 | 1.25.40.10 | |
| Domain | TPR_1 | 1.61e-03 | 90 | 104 | 4 | PF00515 | |
| Domain | TPR_1 | 1.61e-03 | 90 | 104 | 4 | IPR001440 | |
| Domain | Fol_N | 1.63e-03 | 11 | 104 | 2 | IPR003645 | |
| Domain | FOLN | 1.63e-03 | 11 | 104 | 2 | SM00274 | |
| Domain | Kinesin-like_fam | 1.76e-03 | 43 | 104 | 3 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 1.88e-03 | 44 | 104 | 3 | PS00411 | |
| Domain | - | 1.88e-03 | 44 | 104 | 3 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 1.88e-03 | 44 | 104 | 3 | IPR001752 | |
| Domain | Kinesin | 1.88e-03 | 44 | 104 | 3 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 1.88e-03 | 44 | 104 | 3 | PS50067 | |
| Domain | KISc | 1.88e-03 | 44 | 104 | 3 | SM00129 | |
| Domain | UPAR_LY6 | 5.47e-03 | 20 | 104 | 2 | PF00021 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.01e-10 | 18 | 74 | 6 | MM1549 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.54e-07 | 47 | 74 | 6 | MM14939 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 5.55e-07 | 58 | 74 | 6 | MM15149 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.10e-06 | 65 | 74 | 6 | MM15147 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.98e-06 | 40 | 74 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.25e-06 | 41 | 74 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.54e-06 | 42 | 74 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.86e-06 | 43 | 74 | 5 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.01e-06 | 84 | 74 | 6 | MM14929 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 5.54e-06 | 49 | 74 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 6.13e-06 | 50 | 74 | 5 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 6.76e-06 | 51 | 74 | 5 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 9.86e-06 | 55 | 74 | 5 | MM14917 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.28e-05 | 58 | 74 | 5 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION | 2.88e-05 | 169 | 74 | 7 | MM14919 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 3.95e-05 | 73 | 74 | 5 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 6.93e-05 | 82 | 74 | 5 | MM15394 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 8.70e-05 | 86 | 74 | 5 | MM15413 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 8.93e-05 | 202 | 74 | 7 | MM15362 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.20e-04 | 92 | 74 | 5 | MM14951 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.78e-04 | 100 | 74 | 5 | MM14561 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 3.27e-04 | 114 | 74 | 5 | MM15361 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 3.69e-04 | 117 | 74 | 5 | MM15387 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 5.77e-04 | 129 | 74 | 5 | MM14894 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 8.63e-04 | 141 | 74 | 5 | MM15266 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.45e-03 | 11 | 74 | 2 | M22027 | |
| Pathway | PID_RANBP2_PATHWAY | 1.45e-03 | 11 | 74 | 2 | M140 | |
| Pathway | PID_PLK1_PATHWAY | 1.79e-03 | 46 | 74 | 3 | M129 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 RANBP2 RGPD8 ARHGAP23 RGPD1 PRC1 ARHGAP11A ECT2 RGPD3 AKAP13 | 2.00e-03 | 649 | 74 | 10 | MM15690 |
| Pathway | WP_RETT_SYNDROME | 2.03e-03 | 48 | 74 | 3 | M39759 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 2.28e-03 | 257 | 74 | 6 | MM14755 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | RGPD4 RANBP2 RNMT RGPD8 HIPK1 WRN RGPD1 RICTOR MECP2 RGPD3 MLLT1 ZNF844 MGA | 2.35e-03 | 1022 | 74 | 13 | MM15436 |
| Pubmed | ZNF609 TCF20 RGPD8 VEZT MPZL1 MCC HUWE1 NEDD1 TMEM38B CEP350 CEP170 ABLIM1 ALMS1 DCP1B TTLL4 AKAP13 TACC1 PPIP5K2 MGA | 2.54e-12 | 733 | 112 | 19 | 34672954 | |
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 21205196 | ||
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 18949001 | ||
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 25187515 | ||
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 9037092 | ||
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 8603673 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 6.61e-12 | 7 | 112 | 5 | 15710750 | |
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 26632511 | ||
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 24403063 | ||
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 6.61e-12 | 7 | 112 | 5 | 11353387 | |
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 30944974 | ||
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 38838144 | ||
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 6.61e-12 | 7 | 112 | 5 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 6.61e-12 | 7 | 112 | 5 | 17372272 | |
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 38657106 | ||
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 12191015 | ||
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 22821000 | ||
| Pubmed | 6.61e-12 | 7 | 112 | 5 | 20682751 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.76e-11 | 8 | 112 | 5 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.76e-11 | 8 | 112 | 5 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.76e-11 | 8 | 112 | 5 | 28745977 | |
| Pubmed | 1.76e-11 | 8 | 112 | 5 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.76e-11 | 8 | 112 | 5 | 21310149 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 3.95e-11 | 9 | 112 | 5 | 18394993 | |
| Pubmed | 3.95e-11 | 9 | 112 | 5 | 11553612 | ||
| Pubmed | 3.95e-11 | 9 | 112 | 5 | 10601307 | ||
| Pubmed | 3.95e-11 | 9 | 112 | 5 | 9733766 | ||
| Pubmed | 3.95e-11 | 9 | 112 | 5 | 28100513 | ||
| Pubmed | 3.95e-11 | 9 | 112 | 5 | 28877029 | ||
| Pubmed | 3.95e-11 | 9 | 112 | 5 | 17887960 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 7.87e-11 | 10 | 112 | 5 | 8857542 | |
| Pubmed | 7.87e-11 | 10 | 112 | 5 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 7.87e-11 | 10 | 112 | 5 | 16332688 | |
| Pubmed | 7.87e-11 | 10 | 112 | 5 | 21859863 | ||
| Pubmed | RGPD4 RANBP2 ZNF609 TCF20 RGPD8 RAPH1 RGPD1 HUWE1 PIAS2 ALMS1 ZNF532 RGPD3 MGA ZMYM3 | 8.72e-11 | 418 | 112 | 14 | 34709266 | |
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.44e-10 | 11 | 112 | 5 | 35771867 | |
| Pubmed | 1.44e-10 | 11 | 112 | 5 | 17069463 | ||
| Pubmed | 1.44e-10 | 11 | 112 | 5 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 3.99e-10 | 13 | 112 | 5 | 31427429 | |
| Pubmed | 9.26e-10 | 15 | 112 | 5 | 14697343 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PHACTR2 TCF20 RAPH1 MAP4 KIF26B RICTOR SIK3 ECT2 CEP350 CEP170 ABLIM1 ALMS1 DCP1B CNKSR3 AKAP13 PPIP5K2 AHNAK2 | 2.52e-09 | 861 | 112 | 17 | 36931259 |
| Pubmed | ZNF609 ARHGAP23 ADAMTS1 VEZT MCC RICTOR ZC3H18 SIK3 MECP2 CEP170 SOWAHA ALMS1 ATXN7 MLLT1 KIF18B MGA DDX24 LCOR ZMYM3 | 3.00e-09 | 1116 | 112 | 19 | 31753913 | |
| Pubmed | RANBP2 TCF20 KIF26A JADE2 KIF26B HIPK1 SIK3 PIAS2 CEP350 ABLIM1 USF3 AKAP13 MGA | 6.39e-09 | 486 | 112 | 13 | 20936779 | |
| Pubmed | 7.98e-09 | 22 | 112 | 5 | 27717094 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RANBP2 ZNF609 MAP4 PRC1 CPED1 CEP350 CEP170 NOP58 RBM27 AKAP13 KIF18B MGA DDX24 LCOR AHNAK2 | 1.26e-08 | 724 | 112 | 15 | 36232890 |
| Pubmed | ZNF609 RNMT KIF26A JADE2 SIK3 ARHGAP11A USP38 ZNF532 RBM27 TTLL4 PPIP5K2 ACAP2 LCOR | 1.74e-08 | 529 | 112 | 13 | 14621295 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RANBP2 ZNF609 TCF20 WRN ZC3H18 PRC1 ARHGAP11A MECP2 NOP58 NFIA RBM27 RGPD3 MLLT1 KIF18B COIL MGA DDX24 LCOR ZMYM3 | 3.20e-08 | 1294 | 112 | 19 | 30804502 |
| Pubmed | 3.53e-08 | 215 | 112 | 9 | 35973513 | ||
| Pubmed | 4.65e-08 | 222 | 112 | 9 | 37071664 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF609 MAP4 VEZT JADE2 AFF3 HUWE1 NEDD1 CDC14B PLBD2 CEP170 ABLIM1 USF3 ZNF532 NFIA ATXN7 TMPRSS2 AKAP13 FGF13 ALCAM LCOR | 5.72e-08 | 1489 | 112 | 20 | 28611215 |
| Pubmed | ARHGAP23 DGKD RICTOR TMEM200A CEP350 CEP170 USF3 ALMS1 SACS NFIA PLEKHH2 MGA | 7.06e-08 | 493 | 112 | 12 | 15368895 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RANBP2 ZNF609 TCF20 MAP4 ZC3H18 MECP2 CEP170 NOP58 RBM27 ATAD2B MLLT1 KIF18B COIL MGA DDX24 LCOR | 7.38e-08 | 954 | 112 | 16 | 36373674 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TCF20 WRN ZC3H18 ARHGAP11A PIAS2 MECP2 NOP58 NFIA ATAD2B KIF18B MGA DDX24 ZMYM3 | 8.77e-08 | 608 | 112 | 13 | 36089195 |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 9480752 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.46e-07 | 38 | 112 | 5 | 12791264 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RANBP2 TCF20 RAPH1 MAP4 RICTOR ZC3H18 HUWE1 MECP2 ABLIM1 NFIA ATXN7 COIL DDX24 ZMYM3 | 2.09e-07 | 774 | 112 | 14 | 15302935 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | RANBP2 ZNF609 MAP4 NEDD1 PIAS2 CEP170 ABLIM1 ATXN7 RGPD3 MGA AHNAK2 | 2.14e-07 | 444 | 112 | 11 | 34795231 |
| Pubmed | TCF20 RAPH1 MAP4 HUWE1 CEP170 ABLIM1 NOP58 ALMS1 RBM27 COIL MGA RGPD5 | 2.24e-07 | 549 | 112 | 12 | 38280479 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.64e-07 | 283 | 112 | 9 | 30585729 | |
| Pubmed | 3.71e-07 | 86 | 112 | 6 | 37253089 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 4.98e-07 | 146 | 112 | 7 | 23892456 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 7.47e-07 | 226 | 112 | 8 | 37839992 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 RANBP2 ZNF609 RGPD8 RGPD1 MCC PRC1 NEDD1 ECT2 CEP350 CEP170 NOP58 RGPD3 COIL ZMYM3 RGPD5 | 9.44e-07 | 1155 | 112 | 16 | 20360068 |
| Pubmed | RAPH1 ARHGAP23 HUWE1 PRC1 ARHGAP11A ECT2 MECP2 CEP170 ABLIM1 NOP58 CNKSR3 AKAP13 PPIP5K2 MGA | 1.54e-06 | 916 | 112 | 14 | 32203420 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 1.77e-06 | 442 | 112 | 10 | 15815621 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RANBP2 RNMT TCF20 ZC3H18 SIK3 MECP2 CEP170 NOP58 ZNF532 SACS RBM27 PPIP5K2 COIL DDX24 ZMYM3 | 2.11e-06 | 1082 | 112 | 15 | 38697112 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.16e-06 | 351 | 112 | 9 | 38297188 | |
| Pubmed | RANBP2 RAPH1 MAP4 VEZT MPZL1 CEP170 RBM27 RGPD3 TACC1 EIF2AK3 AHNAK2 | 2.37e-06 | 568 | 112 | 11 | 37774976 | |
| Pubmed | RGPD4 RANBP2 TCF20 RGPD8 RGPD1 MCC HUWE1 SIK3 GABBR2 CEP170 ABLIM1 RGPD3 CNKSR3 MGA | 2.75e-06 | 963 | 112 | 14 | 28671696 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | RGPD4 RANBP2 RGPD8 MAP4 RGPD1 PRC1 CEP170 ABLIM1 RBM27 RGPD3 AKAP13 COIL | 2.88e-06 | 701 | 112 | 12 | 30196744 |
| Pubmed | RGPD4 KRT72 RANBP2 PHACTR2 RGPD8 RAPH1 RGPD1 MECP2 SACS ATXN7 RGPD3 CNKSR3 MLLT1 CFAP74 ALCAM PPIP5K2 RGPD5 | 3.72e-06 | 1442 | 112 | 17 | 35575683 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 5.22e-06 | 135 | 112 | 6 | 31077711 | |
| Pubmed | 5.55e-06 | 503 | 112 | 10 | 16964243 | ||
| Pubmed | 5.61e-06 | 210 | 112 | 7 | 16565220 | ||
| Pubmed | HUWE1 PRC1 ARHGAP11A MECP2 CEP350 CEP170 ALMS1 RBM27 KIF18B ACAP2 LCOR | 7.92e-06 | 645 | 112 | 11 | 25281560 | |
| Pubmed | RANBP2 TCF20 MAP4 ZC3H18 HUWE1 CEP170 NOP58 ATAD2B COIL DDX24 ZMYM3 | 8.88e-06 | 653 | 112 | 11 | 22586326 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 33061800 | ||
| Pubmed | DNER and NFIA are expressed by developing and mature AII amacrine cells in the mouse retina. | 1.03e-05 | 2 | 112 | 2 | 29071714 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.04e-05 | 231 | 112 | 7 | 16452087 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 RANBP2 ZNF609 RGPD8 MAP4 RGPD1 ZC3H18 HUWE1 NOP58 RGPD3 DDX24 | 1.05e-05 | 665 | 112 | 11 | 30457570 |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.07e-05 | 153 | 112 | 6 | 26365490 | |
| Pubmed | 1.78e-05 | 99 | 112 | 5 | 27746211 | ||
| Pubmed | RGPD4 RANBP2 RGPD8 MAP4 VEZT RGPD1 RICTOR HUWE1 GABBR2 CEP170 ABLIM1 RGPD3 TACC1 COIL | 1.83e-05 | 1139 | 112 | 14 | 36417873 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 2.02e-05 | 256 | 112 | 7 | 33397691 | |
| Pubmed | 2.16e-05 | 103 | 112 | 5 | 32744500 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ZNF609 MPZL1 DNER DGKD RICTOR NEDD1 TMEM38B ABLIM1 CNKSR3 ALCAM ACAP2 | 2.16e-05 | 719 | 112 | 11 | 35337019 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.32e-05 | 361 | 112 | 8 | 26167880 | |
| Pubmed | 2.41e-05 | 263 | 112 | 7 | 34702444 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 2.69e-05 | 180 | 112 | 6 | 35198878 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 TCF20 ARHGAP23 MAP4 DGKD RICTOR HUWE1 ECT2 NOP58 AKAP13 KIF18B MGA DDX24 ZMYM3 AHNAK2 | 2.99e-05 | 1353 | 112 | 15 | 29467282 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 3.04e-05 | 184 | 112 | 6 | 32908313 | |
| Pubmed | Autism-related protein MeCP2 regulates FGF13 expression and emotional behaviors. | 3.08e-05 | 3 | 112 | 2 | 27916441 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | RANBP2 ZNF609 TCF20 MPZL1 PIAS2 MECP2 TMEM38B ABLIM1 NOP58 ZNF532 RBM27 ALCAM MGA ZMYM3 | 3.33e-05 | 1203 | 112 | 14 | 29180619 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 4.31e-05 | 394 | 112 | 8 | 27248496 | |
| Pubmed | 4.79e-05 | 22 | 112 | 3 | 16524884 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 5.06e-05 | 123 | 112 | 5 | 26912792 | |
| Pubmed | ZNF609 TCF20 RGPD1 IRF1 ZC3H18 PIAS2 ALMS1 DCP1B NFIA RBM27 ATXN7 MLLT1 MGA DDX24 ZMYM3 | 5.56e-05 | 1429 | 112 | 15 | 35140242 | |
| Pubmed | E3 ubiquitin ligase Mule ubiquitinates Miz1 and is required for TNFalpha-induced JNK activation. | 6.14e-05 | 4 | 112 | 2 | 20624960 | |
| Interaction | NUP43 interactions | RANBP2 ZNF609 TCF20 RGPD8 MAP4 WRN RICTOR ZC3H18 CCDC168 PRC1 MECP2 NOP58 ZNF532 NFIA ATAD2B COIL MGA DDX24 LCOR ZMYM3 AHNAK2 RGPD5 | 1.49e-12 | 625 | 107 | 22 | int:NUP43 |
| Interaction | RGPD4 interactions | 1.56e-11 | 22 | 107 | 7 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 7.93e-11 | 27 | 107 | 7 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 1.28e-10 | 47 | 107 | 8 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 6.97e-09 | 49 | 107 | 7 | int:RGPD1 | |
| Interaction | RGPD5 interactions | 4.36e-08 | 96 | 107 | 8 | int:RGPD5 | |
| Interaction | RGPD8 interactions | 1.31e-07 | 74 | 107 | 7 | int:RGPD8 | |
| Interaction | YWHAG interactions | PHACTR2 RAPH1 ARHGAP23 KIF26B SPEG MCC RICTOR HUWE1 SIK3 PRC1 CEP350 CEP170 ABLIM1 ALMS1 DCP1B CNKSR3 MTBP AKAP13 PPIP5K2 ZMYM3 AHNAK2 | 2.13e-06 | 1248 | 107 | 21 | int:YWHAG |
| Interaction | NPIPB6 interactions | 2.17e-06 | 18 | 107 | 4 | int:NPIPB6 | |
| Interaction | KPNA2 interactions | RANBP2 RNMT RGPD8 ARHGAP23 ZC3H18 HUWE1 PRC1 ECT2 MECP2 NOP58 KIF18B COIL RGPD5 | 3.76e-06 | 519 | 107 | 13 | int:KPNA2 |
| Interaction | YWHAH interactions | PHACTR2 TCF20 KIF26B SPEG RICTOR HUWE1 SIK3 ECT2 PIAS2 CEP350 CEP170 ABLIM1 ALMS1 DCP1B CNKSR3 MTBP AKAP13 PPIP5K2 AHNAK2 | 4.96e-06 | 1102 | 107 | 19 | int:YWHAH |
| Interaction | SNRNP40 interactions | ZNF609 TCF20 WRN ZC3H18 PRC1 ECT2 MECP2 NOP58 ZNF532 NFIA ATAD2B COIL MGA DDX24 | 6.98e-06 | 637 | 107 | 14 | int:SNRNP40 |
| Interaction | RRP12 interactions | 7.98e-06 | 320 | 107 | 10 | int:RRP12 | |
| Interaction | POLR1G interactions | TCF20 MCC ZC3H18 HUWE1 MECP2 NOP58 MLLT1 COIL MGA DDX24 LCOR ZMYM3 | 1.12e-05 | 489 | 107 | 12 | int:POLR1G |
| Interaction | SPANXN2 interactions | 1.15e-05 | 95 | 107 | 6 | int:SPANXN2 | |
| Interaction | SFN interactions | MAP4 KIF26B RICTOR ZC3H18 SIK3 ARHGAP11A CEP350 CEP170 ABLIM1 ALMS1 NFIA AKAP13 DDX24 AHNAK2 | 1.77e-05 | 692 | 107 | 14 | int:SFN |
| Interaction | RANBP2 interactions | RGPD4 RANBP2 RGPD8 RGPD1 HUWE1 PRC1 MECP2 RGPD3 AKAP13 RGPD5 | 2.26e-05 | 361 | 107 | 10 | int:RANBP2 |
| Interaction | YWHAB interactions | ARHGAP23 KIF26B SPEG MCC RICTOR SIK3 ECT2 CEP350 CEP170 ABLIM1 DCP1B CNKSR3 MTBP AKAP13 PPIP5K2 DDX24 AHNAK2 | 2.39e-05 | 1014 | 107 | 17 | int:YWHAB |
| Interaction | SYNE3 interactions | RANBP2 TCF20 VEZT NEDD1 CEP350 ABLIM1 ALMS1 DCP1B IQCC TACC1 EIF2AK3 | 2.43e-05 | 444 | 107 | 11 | int:SYNE3 |
| Interaction | ZNF330 interactions | TCF20 ZC3H18 PIAS2 MECP2 NOP58 MLLT1 KIF18B COIL DDX24 LCOR ZMYM3 | 2.54e-05 | 446 | 107 | 11 | int:ZNF330 |
| Interaction | DHX8 interactions | 2.58e-05 | 292 | 107 | 9 | int:DHX8 | |
| Interaction | KPNA4 interactions | 2.69e-05 | 225 | 107 | 8 | int:KPNA4 | |
| Interaction | SRFBP1 interactions | 4.05e-05 | 72 | 107 | 5 | int:SRFBP1 | |
| Interaction | FBLL1 interactions | 4.82e-05 | 38 | 107 | 4 | int:FBLL1 | |
| Interaction | ESRP1 interactions | 5.60e-05 | 77 | 107 | 5 | int:ESRP1 | |
| Interaction | H3C3 interactions | TCF20 ZC3H18 ARHGAP11A PIAS2 MECP2 NOP58 ATAD2B KIF18B MGA DDX24 ZMYM3 | 6.51e-05 | 495 | 107 | 11 | int:H3C3 |
| Interaction | SLC25A11 interactions | 6.52e-05 | 255 | 107 | 8 | int:SLC25A11 | |
| Interaction | SMC5 interactions | RANBP2 ZNF609 TCF20 MAP4 ZC3H18 MECP2 CEP170 NOP58 RBM27 ATAD2B MLLT1 KIF18B COIL MGA DDX24 LCOR | 7.41e-05 | 1000 | 107 | 16 | int:SMC5 |
| Interaction | CDCA8 interactions | 7.73e-05 | 133 | 107 | 6 | int:CDCA8 | |
| Interaction | NUP50 interactions | 8.56e-05 | 341 | 107 | 9 | int:NUP50 | |
| Interaction | YWHAE interactions | KIF26B MCC RICTOR ZC3H18 HUWE1 SIK3 PRC1 CEP170 ABLIM1 DCP1B STK33 CNKSR3 MTBP AKAP13 MGA DDX24 ACAP2 LCOR | 1.04e-04 | 1256 | 107 | 18 | int:YWHAE |
| Interaction | PRPH interactions | 1.09e-04 | 204 | 107 | 7 | int:PRPH | |
| Interaction | BAG2 interactions | ZNF609 TCF20 RICTOR HUWE1 PRC1 NEDD1 ECT2 CEP170 RBM27 STK33 TMPRSS2 PPIP5K2 | 1.15e-04 | 622 | 107 | 12 | int:BAG2 |
| Interaction | RPS24 interactions | RGPD8 ZC3H18 CCDC168 HUWE1 PRC1 ECT2 NOP58 NFIA FGF13 COIL DDX24 | 1.17e-04 | 529 | 107 | 11 | int:RPS24 |
| Interaction | RPS14 interactions | RANBP2 MAP4 RICTOR ZC3H18 HUWE1 PRC1 ECT2 MECP2 NOP58 FGF13 DDX24 | 1.17e-04 | 529 | 107 | 11 | int:RPS14 |
| Interaction | KDM1A interactions | RANBP2 ZNF609 TCF20 RAPH1 HUWE1 ECT2 PIAS2 CEP350 ALMS1 USP38 ZNF532 TACC1 COIL MGA ZMYM3 | 1.32e-04 | 941 | 107 | 15 | int:KDM1A |
| Interaction | RHOB interactions | PAG1 PHACTR2 RAPH1 KIF26A KIF26B MPZL1 DGKD RICTOR ARHGAP11A ECT2 ABLIM1 AKAP13 ALCAM DDX24 | 1.43e-04 | 840 | 107 | 14 | int:RHOB |
| Interaction | SUMO1 interactions | 1.48e-04 | 287 | 107 | 8 | int:SUMO1 | |
| Interaction | KPNB1 interactions | RANBP2 RNMT RGPD8 RGPD1 HUWE1 PRC1 ECT2 MECP2 NOP58 KIF18B LCOR | 1.50e-04 | 544 | 107 | 11 | int:KPNB1 |
| Interaction | NPTX2 interactions | 1.55e-04 | 20 | 107 | 3 | int:NPTX2 | |
| Interaction | BMS1 interactions | 1.64e-04 | 218 | 107 | 7 | int:BMS1 | |
| Interaction | SNRNP200 interactions | 1.70e-04 | 460 | 107 | 10 | int:SNRNP200 | |
| Interaction | COIL interactions | TCF20 ZC3H18 ECT2 PIAS2 MECP2 NOP58 NFIA MLLT1 COIL MGA DDX24 | 1.70e-04 | 552 | 107 | 11 | int:COIL |
| Interaction | CASK interactions | 1.79e-04 | 221 | 107 | 7 | int:CASK | |
| Interaction | YWHAZ interactions | RAPH1 KIF26B SPEG MCC RICTOR ZC3H18 HUWE1 SIK3 ECT2 CEP170 ABLIM1 DCP1B RBM27 CNKSR3 MTBP AKAP13 PPIP5K2 DDX24 | 1.91e-04 | 1319 | 107 | 18 | int:YWHAZ |
| Interaction | SASS6 interactions | 2.06e-04 | 159 | 107 | 6 | int:SASS6 | |
| Interaction | PDZD2 interactions | 2.08e-04 | 22 | 107 | 3 | int:PDZD2 | |
| Interaction | BCOR interactions | 2.09e-04 | 302 | 107 | 8 | int:BCOR | |
| Interaction | DDX56 interactions | 2.19e-04 | 304 | 107 | 8 | int:DDX56 | |
| Interaction | SP7 interactions | 2.19e-04 | 304 | 107 | 8 | int:SP7 | |
| Interaction | PRPF38A interactions | 2.20e-04 | 161 | 107 | 6 | int:PRPF38A | |
| Interaction | RPS10P5 interactions | 2.23e-04 | 56 | 107 | 4 | int:RPS10P5 | |
| Interaction | MAPRE3 interactions | 2.28e-04 | 230 | 107 | 7 | int:MAPRE3 | |
| Interaction | SLX4 interactions | RANBP2 TCF20 AFF3 WRN ARHGAP11A CEP350 NOP58 ATXN7 RGPD3 MLLT1 MGA | 2.31e-04 | 572 | 107 | 11 | int:SLX4 |
| Interaction | SYNGAP1 interactions | 2.34e-04 | 307 | 107 | 8 | int:SYNGAP1 | |
| Interaction | NOP58 interactions | 2.44e-04 | 309 | 107 | 8 | int:NOP58 | |
| Interaction | NKAPL interactions | 2.72e-04 | 24 | 107 | 3 | int:NKAPL | |
| Interaction | DUSP16 interactions | 2.74e-04 | 237 | 107 | 7 | int:DUSP16 | |
| Interaction | ACTN4 interactions | 2.82e-04 | 400 | 107 | 9 | int:ACTN4 | |
| Interaction | SUMO2 interactions | RANBP2 MAP4 WRN HUWE1 PRC1 PIAS2 NOP58 ATXN7 KIF18B ZMYM3 AHNAK2 | 3.06e-04 | 591 | 107 | 11 | int:SUMO2 |
| Interaction | FKBP11 interactions | 3.07e-04 | 25 | 107 | 3 | int:FKBP11 | |
| Interaction | CBX8 interactions | 3.69e-04 | 249 | 107 | 7 | int:CBX8 | |
| Interaction | PFN1 interactions | RANBP2 RAPH1 ZC3H18 CEP350 ABLIM1 ALMS1 DCP1B MLLT1 AKAP13 AHNAK2 | 3.80e-04 | 509 | 107 | 10 | int:PFN1 |
| Interaction | ANXA2 interactions | 3.96e-04 | 419 | 107 | 9 | int:ANXA2 | |
| Interaction | HMGA1 interactions | 3.96e-04 | 419 | 107 | 9 | int:HMGA1 | |
| Interaction | MAPRE1 interactions | RANBP2 RAPH1 VEZT CEP350 CEP170 ABLIM1 ALMS1 TACC1 KIF18B RGPD5 | 4.11e-04 | 514 | 107 | 10 | int:MAPRE1 |
| Interaction | CRX interactions | 4.16e-04 | 254 | 107 | 7 | int:CRX | |
| Interaction | PML interactions | RANBP2 ZNF609 MAP4 HIPK1 WRN NEDD1 ECT2 PIAS2 CEP170 ABLIM1 ATXN7 RGPD3 ZMYM3 AHNAK2 | 4.16e-04 | 933 | 107 | 14 | int:PML |
| Interaction | ESF1 interactions | 4.25e-04 | 182 | 107 | 6 | int:ESF1 | |
| Interaction | CPAP interactions | 4.25e-04 | 182 | 107 | 6 | int:CPAP | |
| Interaction | MECP2 interactions | RANBP2 RNMT TCF20 ARHGAP23 ZC3H18 SIK3 PRC1 MECP2 CEP170 NOP58 ZNF532 SACS RBM27 PPIP5K2 COIL DDX24 ZMYM3 | 4.29e-04 | 1287 | 107 | 17 | int:MECP2 |
| Interaction | LY6G5B interactions | 4.33e-04 | 28 | 107 | 3 | int:LY6G5B | |
| Interaction | BICD2 interactions | 4.47e-04 | 426 | 107 | 9 | int:BICD2 | |
| Interaction | LUC7L3 interactions | 4.63e-04 | 185 | 107 | 6 | int:LUC7L3 | |
| Interaction | BRD2 interactions | 4.70e-04 | 429 | 107 | 9 | int:BRD2 | |
| Interaction | RRS1 interactions | 5.09e-04 | 345 | 107 | 8 | int:RRS1 | |
| Interaction | STIL interactions | 5.33e-04 | 190 | 107 | 6 | int:STIL | |
| Interaction | PARP1 interactions | WRN RICTOR ZC3H18 HUWE1 ECT2 PIAS2 MECP2 CEP170 ABLIM1 NOP58 SACS NFIA MLLT1 KIF18B COIL MGA ZMYM3 | 5.53e-04 | 1316 | 107 | 17 | int:PARP1 |
| Interaction | ZNF30 interactions | 5.76e-04 | 7 | 107 | 2 | int:ZNF30 | |
| Interaction | ZBED4 interactions | 5.87e-04 | 31 | 107 | 3 | int:ZBED4 | |
| Interaction | PWP1 interactions | 6.62e-04 | 198 | 107 | 6 | int:PWP1 | |
| Cytoband | 3q13.1 | 5.87e-05 | 5 | 112 | 2 | 3q13.1 | |
| Cytoband | 5q31.1 | 5.05e-04 | 63 | 112 | 3 | 5q31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q23 | 5.17e-04 | 150 | 112 | 4 | chr12q23 | |
| Cytoband | 2q13 | 6.31e-04 | 68 | 112 | 3 | 2q13 | |
| Cytoband | 2q12.3 | 7.83e-04 | 17 | 112 | 2 | 2q12.3 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.23e-06 | 115 | 67 | 6 | 769 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.14e-04 | 206 | 67 | 6 | 682 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 4.79e-04 | 9 | 67 | 2 | 1280 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 6.59e-04 | 46 | 67 | 3 | 622 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD4 RANBP2 PHACTR2 RNMT RGPD8 HIPK1 AFF3 RGPD1 RICTOR PIAS2 USF3 ATAD2B RGPD3 DDX24 LCOR RGPD5 | 1.50e-10 | 474 | 110 | 16 | M40991 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | RANBP2 RNMT RGPD8 HIPK1 RICTOR SIK3 NEDD1 NOP58 USP38 RBM27 ATXN7 TACC1 DDX24 LCOR EIF2AK3 RGPD5 | 2.57e-08 | 680 | 110 | 16 | M41089 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 2.57e-07 | 33 | 110 | 5 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.01e-06 | 43 | 110 | 5 | MM3857 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 3.73e-06 | 289 | 110 | 9 | M2196 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | RANBP2 ZNF609 RGPD8 OSER1 RICTOR NOP58 ATXN7 DDX24 EIF2AK3 RGPD5 | 1.44e-05 | 432 | 110 | 10 | M41149 |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN | 1.77e-05 | 193 | 110 | 7 | M4284 | |
| Coexpression | GSE45365_CD8A_DC_VS_CD11B_DC_UP | 2.02e-05 | 197 | 110 | 7 | M9997 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 2.22e-05 | 200 | 110 | 7 | M9317 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 2.31e-05 | 363 | 110 | 9 | M41103 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | 3.95e-05 | 389 | 110 | 9 | M39073 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | GLT8D2 RANBP2 PHACTR2 RNMT RAPH1 SPEG MCC DGKD HUWE1 PRDM4 TMEM38B USF3 ALCAM DDX24 | 4.26e-05 | 946 | 110 | 14 | M39169 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RANBP2 PAG1 ZNF609 JADE2 HIPK1 IRF1 RICTOR HUWE1 SIK3 MECP2 CEP350 SACS RBM27 ATXN7 AKAP13 TACC1 DDX24 ACAP2 | 4.78e-05 | 1492 | 110 | 18 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 WRN SIK3 ARHGAP11A MECP2 CEP350 CEP170 SACS ATAD2B AKAP13 ALCAM PPIP5K2 ACAP2 | 6.28e-05 | 856 | 110 | 13 | M4500 |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | 6.36e-05 | 236 | 110 | 7 | M130 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 6.63e-05 | 163 | 110 | 6 | M8235 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | RGPD4 GLT8D2 RANBP2 ZNF609 RNMT RGPD8 VEZT RGPD1 SIK3 ARHGAP11A ECT2 NFIA RGPD3 KIF18B DDX24 EIF2AK3 | 8.50e-05 | 1277 | 110 | 16 | MM1032 |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | 1.25e-04 | 183 | 110 | 6 | M8189 | |
| Coexpression | ALONSO_METASTASIS_DN | 1.74e-04 | 26 | 110 | 3 | M17331 | |
| Coexpression | GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN | 1.92e-04 | 198 | 110 | 6 | M9346 | |
| Coexpression | GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN | 1.92e-04 | 198 | 110 | 6 | M6511 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP | 2.03e-04 | 200 | 110 | 6 | M4590 | |
| Coexpression | GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN | 2.03e-04 | 200 | 110 | 6 | M6989 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | IGFN1 RAPH1 ARHGAP23 SPEG AFF3 DNER RICTOR SIK3 GABBR2 PIAS2 PAPPA SRRM3 RFPL3S AHNAK2 | 2.20e-04 | 1106 | 110 | 14 | M39071 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Mesoderm Day 15-Confounder_removed-fold2.0_adjp0.05 | RGPD4 ZNF609 PHACTR2 RGPD8 KIF26A MCC LYPD2 ARHGAP11A ECT2 NOP58 ZNF532 ATXN7 TTLL4 RGPD3 TMPRSS2 AKAP13 FGF13 ACAP2 C13orf42 RGPD5 | 7.97e-06 | 1276 | 110 | 20 | PCBC_ratio_MESO-5_vs_MESO-15_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | RAPH1 KIF26B AFF3 MCC PRC1 ARHGAP11A ECT2 CPED1 CDC14B NFIA KCNH1 FGF13 ALCAM PLEKHH2 ZMYM3 | 9.98e-06 | 768 | 110 | 15 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274 | 5.68e-05 | 256 | 110 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | 7.62e-05 | 427 | 110 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | PAG1 TCF20 MAP4 VEZT KIF26A KIF26B WRN DNER HUWE1 CEP350 CEP170 NFIA FGF13 LCOR | 8.45e-05 | 818 | 110 | 14 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.40e-09 | 191 | 112 | 9 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.98e-07 | 188 | 112 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 5.34e-07 | 190 | 112 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.42e-06 | 169 | 112 | 6 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 4.58e-06 | 170 | 112 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.35e-06 | 180 | 112 | 6 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.77e-06 | 182 | 112 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.98e-06 | 183 | 112 | 6 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.66e-06 | 186 | 112 | 6 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 8.39e-06 | 189 | 112 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-06 | 190 | 112 | 6 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-06 | 190 | 112 | 6 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.65e-06 | 190 | 112 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.91e-06 | 191 | 112 | 6 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.18e-06 | 192 | 112 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.18e-06 | 192 | 112 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 193 | 112 | 6 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.46e-06 | 193 | 112 | 6 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 193 | 112 | 6 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.46e-06 | 193 | 112 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 9.46e-06 | 193 | 112 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 193 | 112 | 6 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 9.46e-06 | 193 | 112 | 6 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.46e-06 | 193 | 112 | 6 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 193 | 112 | 6 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 9.74e-06 | 194 | 112 | 6 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.74e-06 | 194 | 112 | 6 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-05 | 195 | 112 | 6 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-05 | 200 | 112 | 6 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-05 | 200 | 112 | 6 | b0ba486b55be18a4236bd2644f02352651f4b1fe | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 158 | 112 | 5 | ee8ce3cd202807df692b28bb1a81827d49d73862 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.12e-05 | 159 | 112 | 5 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.43e-05 | 161 | 112 | 5 | 2fe77af3b41e6eacb707a64feea18f9991618173 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.59e-05 | 162 | 112 | 5 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.83e-05 | 169 | 112 | 5 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.83e-05 | 169 | 112 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-05 | 172 | 112 | 5 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-05 | 172 | 112 | 5 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.63e-05 | 173 | 112 | 5 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.63e-05 | 173 | 112 | 5 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.84e-05 | 174 | 112 | 5 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.84e-05 | 174 | 112 | 5 | 41eb0a214a8b4015a26311f77061c8147144f0e7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.84e-05 | 174 | 112 | 5 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.06e-05 | 175 | 112 | 5 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.06e-05 | 175 | 112 | 5 | 38dec78efc99fe23479cba68cfa441e62bd6a08b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.50e-05 | 177 | 112 | 5 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.50e-05 | 177 | 112 | 5 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.73e-05 | 178 | 112 | 5 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.96e-05 | 179 | 112 | 5 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 9.20e-05 | 180 | 112 | 5 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.44e-05 | 181 | 112 | 5 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | 0370b395ceb9d4d66f80cf60dd8c28ac60af5c7b | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.69e-05 | 182 | 112 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.94e-05 | 183 | 112 | 5 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 9.94e-05 | 183 | 112 | 5 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.02e-04 | 184 | 112 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-04 | 184 | 112 | 5 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 185 | 112 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-04 | 185 | 112 | 5 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 185 | 112 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-04 | 186 | 112 | 5 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.10e-04 | 187 | 112 | 5 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.10e-04 | 187 | 112 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 188 | 112 | 5 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 188 | 112 | 5 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.16e-04 | 189 | 112 | 5 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 1.16e-04 | 189 | 112 | 5 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.16e-04 | 189 | 112 | 5 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-ELP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-04 | 189 | 112 | 5 | af391c321753743709e2da01a5aa7782d8cc54e3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-04 | 189 | 112 | 5 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-04 | 189 | 112 | 5 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-04 | 190 | 112 | 5 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 190 | 112 | 5 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-04 | 190 | 112 | 5 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.19e-04 | 190 | 112 | 5 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-04 | 190 | 112 | 5 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 191 | 112 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 191 | 112 | 5 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 192 | 112 | 5 | f053b89bfd6048c227667ff01c38df7c51d8a496 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.25e-04 | 192 | 112 | 5 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.25e-04 | 192 | 112 | 5 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.25e-04 | 192 | 112 | 5 | c4efc170852abbcf0c53c2b0f8a0cc9fe7f116c8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 192 | 112 | 5 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 192 | 112 | 5 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.28e-04 | 193 | 112 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.28e-04 | 193 | 112 | 5 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 193 | 112 | 5 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 193 | 112 | 5 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 193 | 112 | 5 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 193 | 112 | 5 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.28e-04 | 193 | 112 | 5 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 194 | 112 | 5 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 194 | 112 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-04 | 194 | 112 | 5 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 195 | 112 | 5 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 195 | 112 | 5 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.34e-04 | 195 | 112 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 195 | 112 | 5 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 195 | 112 | 5 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| Disease | cerebral amyloid angiopathy | 3.58e-05 | 51 | 107 | 4 | EFO_0006790 | |
| Disease | hip bone mineral density | 9.84e-05 | 126 | 107 | 5 | EFO_0007702 | |
| Disease | Rett Syndrome | 1.29e-04 | 5 | 107 | 2 | C0035372 | |
| Disease | non-syndromic X-linked intellectual disability (is_implicated_in) | 1.29e-04 | 5 | 107 | 2 | DOID:0050776 (is_implicated_in) | |
| Disease | erectile dysfunction | 4.80e-04 | 42 | 107 | 3 | EFO_0004234 | |
| Disease | neuroimaging measurement, brain volume measurement | 6.27e-04 | 286 | 107 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | brain measurement, neuroimaging measurement | 8.99e-04 | 550 | 107 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | eye morphology measurement | 1.21e-03 | 218 | 107 | 5 | EFO_0007858 | |
| Disease | response to acetylsalicylate | 1.51e-03 | 16 | 107 | 2 | GO_1903492 | |
| Disease | neuroimaging measurement | KIF26B AFF3 RGPD1 ABLIM1 NFIA CNKSR3 PAPPA IQCJ-SCHIP1 ALCAM KIF18B EIF2AK3 | 1.74e-03 | 1069 | 107 | 11 | EFO_0004346 |
| Disease | hair colour measurement | 1.82e-03 | 615 | 107 | 8 | EFO_0007822 | |
| Disease | cognitive function measurement | GABRG3 TCF20 MAP4 AFF3 WRN POM121L2 CDC14B ALMS1 NFIA CNKSR3 FGF13 TACC1 IQCJ-SCHIP1 | 2.07e-03 | 1434 | 107 | 13 | EFO_0008354 |
| Disease | body surface area | 2.40e-03 | 643 | 107 | 8 | EFO_0022196 | |
| Disease | platelet crit | 2.44e-03 | 952 | 107 | 10 | EFO_0007985 | |
| Disease | lymphocyte count | RAPH1 DNER OSER1 IRF1 DGKD ALMS1 NFIA ATAD2B RETNLB PAPPA FGF13 PPIP5K2 ACAP2 | 2.48e-03 | 1464 | 107 | 13 | EFO_0004587 |
| Disease | Liver carcinoma | 2.53e-03 | 507 | 107 | 7 | C2239176 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.57e-03 | 801 | 107 | 9 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | Carcinoma of lung | 3.14e-03 | 23 | 107 | 2 | C0684249 | |
| Disease | response to radiation, Hematuria | 3.14e-03 | 23 | 107 | 2 | GO_0009314, HP_0000790 | |
| Disease | brain stem volume measurement | 3.41e-03 | 24 | 107 | 2 | EFO_0010605 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VEKCSSKTCSKPSEN | 106 | O75410 | |
| SLFTSASSSKKPKAD | 906 | P51826 | |
| RCSTGSPSKDVTKSS | 966 | Q5SW79 | |
| TKGPEKLKQSGSTDC | 816 | Q96N23 | |
| KLTAFKPTSSKSSSE | 836 | Q9NZJ5 | |
| LSSKKAEGTPCISKE | 156 | A4D0V7 | |
| GKLCSSEKSKVTSSE | 11 | O14639 | |
| CSSTSPGVKKIRSST | 21 | O60729 | |
| KGKSSPICSTTGDDK | 646 | Q12802 | |
| LCPKTSSKLDSGTLD | 3051 | Q8TCU4 | |
| STSSKSSKGGKKTPV | 116 | A0A1B0GVH6 | |
| SEKLDKKSSPSTGSL | 371 | Q15057 | |
| TTLKKSEKSGFSSPS | 321 | Q12857 | |
| SGSESKVEPKKCELS | 2566 | P49792 | |
| SSNLKTPSKLCSGSK | 791 | Q9P2N5 | |
| DKSGSPGKKTSKTSS | 951 | Q70E73 | |
| TPTKGSSNTEFKSTK | 896 | Q99666 | |
| TPTKGSSNTEFKSTK | 896 | O14715 | |
| GSTCKKISGSVTSAK | 721 | Q9UHI8 | |
| DTPKSCTKSSKSSTP | 431 | Q9H8V3 | |
| CTKSSKSSTPVPSKQ | 436 | Q9H8V3 | |
| AKSKAKRKSCGDSSP | 131 | P10914 | |
| SKSPEILSSTKAGCT | 436 | Q4KMZ1 | |
| SGDSTLPTCSKKRKI | 431 | Q9Y2X3 | |
| DKKSPESSAKSTCRS | 431 | Q9P2G4 | |
| KTGNSESKKKPCSET | 56 | P27816 | |
| TKSSLNKGCSNKPTT | 306 | Q8NHV4 | |
| ASSVSSPVKSKGKIC | 51 | Q8IWI9 | |
| PSVSSSAFCSAKKLK | 11 | Q86Z02 | |
| KKPGSSVKVSCKASG | 31 | P01742 | |
| PDSVCKDKSKSRSTG | 96 | Q9ULI0 | |
| PSGKTKDASSSSKLF | 1641 | Q2KJY2 | |
| SKPKTLLCSKGSSFR | 286 | Q6ZUT3 | |
| SASRCSKLPSSTKSG | 26 | Q9NQC1 | |
| STKKSPCAGSTSLSH | 86 | Q96JN0 | |
| KRKGSVSVCSKESPS | 231 | P38432 | |
| TKASGEATLKKTDSC | 866 | O95259 | |
| ACSGSLKASPTSKKG | 1331 | Q9ULI4 | |
| KLKASTPKSITSASC | 126 | Q6UWN0 | |
| KKAIKDLGISPSTCS | 211 | Q9H1C3 | |
| SKKTTGSKASASPST | 226 | O75167 | |
| GDCCTSTVKTKKVTP | 1581 | Q13219 | |
| GTQGKLTCKFKSTST | 51 | O95297 | |
| CSSPSGDSKLVQKKL | 221 | Q96KD3 | |
| KKPGSSVKVSCKASG | 31 | A0A0B4J2H0 | |
| TTSEEKGKKSSKSCG | 3246 | Q7Z6Z7 | |
| KPTSSLPGTSACKKK | 771 | Q86Y91 | |
| LPGTSACKKKRVASS | 776 | Q86Y91 | |
| SSSDPKGGKLSSESK | 1111 | Q6R327 | |
| KLIGKKRKCSPSSSS | 831 | O15265 | |
| QKLPKTCSSSSDNGK | 686 | Q8IVE3 | |
| DSTVTKSCASKCKPS | 66 | Q6UXB3 | |
| PSAKGKNKAFSTCSS | 216 | Q9H208 | |
| SGSESKVEPKKCELS | 1591 | A6NKT7 | |
| PSPISKKLSCASVKS | 46 | Q9BQ08 | |
| KKLSCASVKSQGRPS | 51 | Q9BQ08 | |
| KTCSEPKKITSSSAI | 176 | Q8IZD4 | |
| SLSSTSSGSKDKPGK | 681 | P23508 | |
| SSCRKPTTTKKTTSL | 341 | Q99928 | |
| SKHSLPKSCTSVSKQ | 1991 | Q5VT06 | |
| PKSCTSVSKQESSKG | 1996 | Q5VT06 | |
| KRGSKPSASSASLEK | 321 | Q9Y5N1 | |
| LVKESSSCGKDTPSK | 66 | O43148 | |
| SAPSKSESALSCLSK | 821 | Q9GZR7 | |
| SKSPCEKLISKGSLS | 681 | Q16760 | |
| KCVSSPSKGKTSCDK | 26 | Q92913 | |
| SFSNDPCTSVKKLKG | 231 | O75899 | |
| DSSKYKISSSPGSKE | 71 | Q86VF2 | |
| ALTTSTAKPKCVNTK | 1356 | Q8NDH2 | |
| SSSFSDKKPAKDKSS | 321 | Q03111 | |
| SEKGSSKKLASPTSS | 661 | Q6UWX4 | |
| GKGKCTTKPSEATFS | 321 | Q8NFT8 | |
| KKSCSSKALNTPVLS | 1716 | Q9NZJ4 | |
| TCSSSNKKLPSDEPK | 1741 | Q9NZJ4 | |
| TKKTDPSGLSKTIIC | 421 | Q13740 | |
| SVPLKCSTKKCSLSL | 606 | Q9C0B2 | |
| SCETPKLATKTSSGQ | 796 | Q96DY7 | |
| TRHLKTCKGPTSSSS | 746 | Q9UKN5 | |
| SKPCSVTVASEASKK | 451 | O75928 | |
| TPTKGSSNTEFKSTK | 881 | P0DJD0 | |
| LKTCKSPGRKSKESS | 336 | P51608 | |
| SGSESKVEPKKCELS | 1591 | Q7Z3J3 | |
| SASKDSSVSCIKSGP | 886 | Q6P4F7 | |
| SSVSCIKSGPKEQKS | 891 | Q6P4F7 | |
| CSCGSSSPLRKKKKS | 191 | A6NNA2 | |
| LDKKSTKCPDCSSAS | 6 | Q9BYT3 | |
| PSKTTDDKTSGSKKC | 261 | Q86VY9 | |
| PLGKSTVCSATSSQK | 96 | Q5VWT5 | |
| SGSKPVAASTCSGKK | 521 | O43663 | |
| SKSSSTLTKGCHDSP | 1111 | Q9Y2K2 | |
| LPSSKTVSSGTKEHC | 1076 | Q14191 | |
| TSCSKSGKPSLSSRL | 356 | B3KU38 | |
| ATDDTKPKTTCASKD | 46 | Q9NX31 | |
| SGKAKSTSASKELPG | 201 | Q9NWQ8 | |
| SASSFSIGAKSKTPK | 1006 | Q96KW2 | |
| CFKESCESTSLKKTP | 1386 | Q8TER0 | |
| KLGFSSSPTKKSKST | 5701 | Q8IVF2 | |
| KKSGSSATKSSSTEP | 526 | Q6P9H4 | |
| KECGKAFSTSSPLAK | 291 | P17039 | |
| VAPSKTKSSSKLSSC | 256 | Q9HCE3 | |
| SPSGTVCTSKTKKAL | 71 | O15393 | |
| KKSKSSGPSLAGTAE | 356 | Q15772 | |
| LKKSSSFSKFLSASP | 496 | Q2M3V2 | |
| VKRKTSCSASGQKPT | 46 | P0C7P2 | |
| TTCSSAKSKGSWAPK | 1141 | Q9P227 | |
| SPSPSSKFSTKGLCK | 576 | O15014 | |
| PSVTCKSSSESKALD | 1286 | O15014 | |
| FSSCEKKSEAKSPSN | 251 | Q9NVV0 | |
| EKPSCSLGIKTSNAS | 1211 | Q68DE3 | |
| SKRPSSSKKADSCTN | 486 | Q9UGU0 | |
| LPCKKAATEGSSEKT | 1806 | Q9UGU0 | |
| AKKLKPSGTDEASCT | 821 | Q8NB14 | |
| TLNKKTSPGVKSCES | 91 | Q08AG5 | |
| NKTKIKPSLGSGSCS | 231 | Q8NHP8 | |
| TLKSTKASSKPATSG | 1196 | O43314 | |
| CSSLSPKTEKCTTEG | 31 | Q9HBM0 | |
| FSKSETSKLGKQSSC | 1106 | Q14679 | |
| SSSCLTTFSKKPSGK | 336 | Q14202 | |
| TTFSKKPSGKKTCTF | 341 | Q14202 | |
| SKSSSKVTSVPGKAS | 896 | Q86VM9 | |
| LAKTSGSSCATKKAS | 496 | Q14CN4 |